Modulation of hypothalamic norepinephrine release by atrial natriuretic peptide: involvement of cyclic GMP

Eur J Pharmacol. 1992 Mar 31;213(3):317-21. doi: 10.1016/0014-2999(92)90619-f.

Abstract

The ability of atrial natriuretic peptide (ANP) to modulate K+-stimulated release of [3H]norepinephrine ([3H]NE) from rat hypothalamic slices was investigated. ANP-(1-28) significantly decreased K+-stimulated [3H]NE release in a concentration-dependent manner (maximal inhibition = 22% of control with 100 nM, ED50 = 70 pM). Pretreatment with pertussis toxin did not alter the response to ANP. 8Br-cGMP (10 microM), a cGMP analog, significantly decreased [3H]NE release and when combined with 10 nM ANP-(1-28), an additive effect was observed. Additionally, 3-isobutyl 1-methylxanthine (IBMX) (200 microM), a phosphodiesterase inhibitor, combined with ANP-(1-28) 10 nM, significantly decreased [3H]NE release. These results indicate that ANP-(1-28) modulated release of [3H]NE from rat hypothalamic slices and the effect is most likely mediated by elevation of intraneuronal cGMP.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Animals
  • Atrial Natriuretic Factor / pharmacology*
  • Cyclic GMP / physiology*
  • Hypothalamus / anatomy & histology
  • Hypothalamus / drug effects*
  • Hypothalamus / metabolism
  • In Vitro Techniques
  • Kinetics
  • Male
  • Norepinephrine / metabolism*
  • Potassium / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Receptors, Atrial Natriuretic Factor
  • Receptors, Cell Surface / drug effects
  • Receptors, Cell Surface / physiology
  • Second Messenger Systems / drug effects
  • Second Messenger Systems / physiology
  • Stimulation, Chemical
  • Tritium

Substances

  • Receptors, Cell Surface
  • Tritium
  • Atrial Natriuretic Factor
  • Receptors, Atrial Natriuretic Factor
  • Cyclic GMP
  • Potassium
  • 1-Methyl-3-isobutylxanthine
  • Norepinephrine